The world’s first personalised skin cancer vaccine is being tested on patients in the United Kingdom.

It’s tailored to each patient to search for their cancer cells and prevent the disease from returning.

Developed by Moderna and MSD the jab is now being rolled out for a final trial after promising results.

“I think this whole area of immunotherapy for cancer is probably one of the most exciting developments in modern cancer therapy,” says University of Warwick UK Molecular Oncology Professor Lawrence Young.

“It comes after many, many years of fundamental research into how the body's immune system is regulated.”